Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 4, 2005, Pages 398-405

  Binesh, Nader ^a,e   Huda, Amir ^a,b   Bugbee, Mary ^a   Gupta, Rakesh ^c   Rasgon, Natalie ^a   Kumar, Anand ^a   Green, Michael ^a,d   Han, Steven ^a   Thomas, M Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral metabolites; COSY; Hepatic encephalopathy; MR spectroscopy; Neuropsychology

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; TAURINE; THREONINE;

ADULT; ARTICLE; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; IMAGE ANALYSIS; MALE; METABOLITE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; STATISTICAL SIGNIFICANCE;

BRAIN; FEMALE; GLUTAMIC ACID; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 15944403453     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20291     Document Type: Article

References (33)

1. Von Dhal S, Kircheis G, Haussinger D. Hepatic encephalopathy as a complication of liver disease. World J Gastroenterol 2001;7:152-159.
2. Colquhoun SD, Lipkin C, Connelly CA. The pathophysiology, diagnosis, and management of acute hepatic encephalopathy. Adv Intern Med 2001;46:155-176.
3. Butterworth RF. Complication of cirrhosis. III. Hepatic encephalopathy. J Hepatol 2000;32:171-180.
4. Butterworth RF. Hepatic encephalopathy. Neurologist 1995;1:95-104.
5. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier Jr RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-521.
6. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. 1. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622-630.
7. Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984;86:1421-1427.
8. McCrea M, Cordoba I, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996;53:758-763.
9. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998;134:361-377.
10. Lockwood AH. "What's in a name?" Improving the care of cirrhotics. J Hepatol 2000;32:859-861.
11. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-773.
12. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
13. Butterworth RF. Hepatic encephalopathy: a neuropsychiatric disorder involving multiple neurotransmitter systems. Curr Opin Neurol 2000;13:721-727.
14. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the human brain in chronic hepatic encephalopathy detected with MR spectroscopy. Radiology 1992;182:19-27.
15. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopy abnormalities. Radiology 1994; 193:457-463.
16. 1H MR spectroscopy and neuropsychological status of patients with hepatic encephalopathy. AJR Am J Roentgenol 1998;171:1123-1130.
17. Huda A, Guze B, Thomas MA, et al. Regional variations of metabolites in hepatic encephalopathy. In: Proceedings of the 3rd Annual Meeting of ISMRM, Nice, France, 1995. p 1838.
18. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997;112:1610-1616.
19. Thomas MA, Yue K, Binesh N, et al. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 2001;46:58-67.
20. Hilgier W, Law RO, Zielinska M. Taurine, glutamine, glutamate, and aspartate content and efflux, cell volume of cerebrocortical minislices of rats with hepatic encephalopathy. Adv Exp Med Biol 2000;483:305-312.
21. Lavoie J, Giguere JF, Layrargues GP, Butterworth RF. Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 1987;49:692-697.
22. Butterworth RF. Taurine in hepatic encephalopathy. Adv Exp Med Biol 1996;403:601-606.
23. Gesmar H, Led JJ, Abildgaard F. Improved methods for quantitative spectral analysis of NMR data. Prog NMR Spectrosc 1990;22: 255-288.
24. Banakar S, Venkatraman TN, Yue K, Binesh N, Thomas MA. Asymmetry of localized two-dimensional shift correlated MR spectroscopy. In: Proceedings of the International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences, Las Vegas, 2002. p 500-504.
25. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13:129-153.
26. Binesh N, Yue K, Fairbanks L, Thomas MA. Reproducibility of localized correlated 2D MR spectroscopy. Magn Reson Med 2002; 48:942-948.
27. Lezak MD. Neuropsychological assessment. Oxford University Press: New York: 1995. p 333-685.
28. McLachlan GJ. Discriminant analysis and statistical pattern recognition. John Wiley & Sons: New York: 1992. p 101-167.
29. Basilevsky AT. Statistical factor analysis and related methods: theory and application. John Wiley & Sons: New York; 1994. p 134-213.
30. Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, et al. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994;20:1173-1178.
31. 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 1999;156:952-954.
32. Weissenborn K, Ruckert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998;4: 646-653.
33. Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJF, Bell JD. Cerebral proton and phosphorous-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999;19:389-398.